Seeking Alpha

Endo Health to acquire Paladin Labs for $1.6B

  • Endo Health Solutions (ENDP) has agreed to acquire Canadian peer Paladin Labs (PLDLF) for about $1.6B in a cash and stock deal that will expand Endo's presence in emerging markets as well as in Canada.
  • Endo will pay C$77 ($73.98) a share, representing a premium of over 20% to Paladin's close yesterday.
  • Endo expects the deal to be immediately accretive to its 2014 adjusted EPS.
  • Endo's shares are +2.3%. (Endo's Q3 earnings). (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: